Attenuated Gastric Ulcers, Seizures, Brain Lesions, Hepatomegaly, Fatty Liver, Breakdown of Liver Glycogen, Profound Hypoglycemia and Calcification in Rats
For Intramuscular or Slow Intravenous Use: This product description was generated by AI and is intended for informational purposes only
Heres what we do know from the few human reports available, and why they offer limited reassurance: Phase I trial (unpublished): In 2015, a formal Phase I trial on 42 healthy volunteers was initiated to assess BPC-157s safety and pharmacokinetics
The stable gastric pentadecapeptide BPC 157 pleiotropic beneficial activity and its possible relations with neurotransmitter activity
There are currently over 80 US FDA-approved peptide medications
HUBERMAN: It's what makes us feel sleepy and go to sleep